Cancer vaccine for dogs appears to nearly double survival rate
Yale researchers have developed a cancer vaccine for dogs that appears to increase their 12-month survival rate from 35% to 60%.
How to stop our immune systems from turning on us
From "inverse vaccines" to repurposed cancer therapies, several potential cures for autoimmune diseases are showing serious promise.
World’s first malaria vaccination campaign launches in Cameroon
Cameroon has launched the world’s first malaria vaccine program — a huge milestone on the path to a malaria-free future.
Moderna’s mRNA cancer vaccine works even better than thought
Adding Moderna’s mRNA cancer vaccine to a standard melanoma treatment dramatically reduces the risk of death or recurrence.
The 5 most exciting clinical trial results of 2023
In 2023, several potentially game-changing meds, including ones to treat pain and high cholesterol, showed huge promise in human trials.
World’s first “self-amplifying” vaccine approved in Japan
The approval of the first saRNA vaccine could signal a new era in how we prevent and treat everything from infections to cancer.
World’s first chikungunya vaccine approved in US
The FDA has just approved French biotech company Valneva’s Ixchiq, making it the world’s first chikungunya vaccine.
How AI played an instrumental role in making mRNA vaccines
Years before Moderna created an effective mRNA vaccine against COVID, the company put into place AI systems to accelerate the research process.
Why 20 women were just deliberately exposed to Zika
In a first-of-its-kind human challenge trial, Johns Hopkins University researchers deliberately exposed 20 women to the Zika virus.
Why aren’t we moving faster on malaria vaccines?
COVID-19 shots were rolled out within weeks of approval. The malaria jab is being delayed until mid-2024. Why?
New superbug vaccine turns the immune system into “the Hulk”
A superbug vaccine that temporarily puts the immune system on high alert could reduce the number of hospital-associated infections.
Where are the universal coronavirus vaccines?
Universal coronavirus vaccines that protect against all known variants of COVID-19 — and ones that don't exist yet — are closer than ever.
New “inverse vaccines” could be key to curing autoimmune disorders
"Inverse vaccines" that teach the immune system to tolerate triggering molecules could be the key to curing autoimmune disorders.
Here’s what’s new in the latest COVID-19 boosters
The FDA has approved new COVID-19 boosters from Moderna and Pfizer-BioNTech. Here’s what you need to know about the shots.
Vaccine for common virus could prevent MS
An experimental vaccine designed to prevent an EBV infection might also prevent cancer and multiple sclerosis.
MIT’s vaccine-enhanced CAR-T cell therapy destroys solid tumors
Adding a cancer vaccine to CAR-T cell therapy, a revolutionary treatment for blood cancers, boosts its efficacy against solid tumors.
New meningitis vaccine is the first to cover new emerging strain
A new meningitis vaccine that protects against five bacterial strains outperformed an existing shot in a phase 3 trial.
Personalized mRNA vaccine preps the body to battle deadly cancer
A new pancreatic cancer vaccine based on mRNA tech was shown to be safe and capable of triggering an immune response in a small trial.
Bird flu is everywhere. Are the vaccines ready?
As avian influenza continues to devastate the bird population and jump into mammals, scientists are preparing to protect two important groups.
Scientists have discovered how to make almost any vaccine more potent
An approach called “rational vaccinology” could allow us to design more powerful vaccines, just by rearranging their ingredients.
New approach for mRNA HIV vaccine passes first human trial
There is currently no HIV vaccine, but a new technique which produced specific immunity cells in humans may pave the way to one.